Company Filing History:
Years Active: 2011-2015
Title: **Ivanka Kolenc: A Trailblazing Inventor in Novel Pharmaceutical Formulations**
Introduction
Ivanka Kolenc, an innovative figure based in Novo Mesto, Slovenia, has made significant contributions to the field of pharmaceuticals through her inventive spirit. With a total of two patents to her name, she has been instrumental in advancing formulations that enhance the delivery and stability of active ingredients.
Latest Patents
Among Ivanka's notable patents is "Stable aqueous formulations comprising poorly water soluble active ingredients." This formulation is particularly designed for medical or non-medical use in the rearing of animals. It excels in stability and allows for the administration of active ingredients via animals' drinking water. Additionally, she holds a patent for a "Process for the preparation of levocetirizine and intermediates thereof." This invention reveals a novel procedure for synthesizing levocetirizine and its pharmaceutically acceptable acid addition salts, utilizing diglycolic acid and innovative intermediates.
Career Highlights
Ivanka has built her career with reputable organizations, including Krka d.d. and Krka, Tovarna Zdravil d.d., both located in Novo Mesto. The experience gained in these esteemed companies has greatly contributed to her growth as an inventor. Her work has not only focused on developing stable formulations but also on ensuring that they meet the demanding needs of the pharmaceutical industry.
Collaborations
Throughout her career, Ivanka has collaborated with esteemed colleagues, notably Denise Leskovar and Franc Vrecer. These partnerships have enabled her to share ideas, refine her inventions, and push the boundaries of innovation in her field.
Conclusion
Ivanka Kolenc exemplifies the spirit of innovation within the pharmaceutical industry. Her dedication to developing stable formulations for poorly water-soluble active ingredients not only advances scientific knowledge but also contributes to real-world applications in animal health and pharmaceuticals. Through her patents and collaborative efforts, she continues to pave the way for future advancements in her field.